Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Werner syndrome helicase is an enzyme encoded by the WRN gene. It belongs to the RecQ family of DNA helicases and possesses both 3'-5' DNA helicase and 3'-5' exonuclease activities. The protein plays a critical role in maintaining genome stability by participating in various aspects of DNA metabolism, including replication, repair, recombination, transcription, and telomere maintenance. Mutations in the WRN gene cause Werner syndrome—an autosomal recessive disorder characterized by premature aging, increased cancer predisposition, and genomic instability.
Inhibition of helicase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Werner syndrome helicase.